QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the use of all QIAstat-Dx® Gastrointestinal (GI) Panels on the ...
Sennheiser announced that new components of the EW-DX microphone system are shipping and available to customers. With initial components released in 2022, EW-DX simplifies professional workflows by ...
The QIAstat-Dx panel will provide actionable insights in about one hour, analyzing more than 20 pathogens that cause meningitis / encephalitis syndromes, including bacteria, viruses and yeast and ...
QIAstat-Dx Analyzer 2.0 with Software 1.6 release enables mobile access to test results, streamlining diagnostic processes and enhancing patient care // QIAstat-Dx Analyzer 2.0 also offers enhanced ...
Berkeley Prep’s brand-new chapel relies on Sennheiser EW-DX for services. Berkeley Preparatory School, a Pre-K to Grade 12 day school in Tampa, has a jam-packed schedule of activities for its 1,400+ ...
The CFX Opus 96 Dx System and the CFX Opus 384 Dx Real-Time PCR Systems Offer Accurate and Precise Quantification to Improve IVD Assay Development and Diagnostic Testing. Bio-Rad Laboratories, Inc.
QIAGEN N.V. QGEN recently achieved CE-IVDR certification for its full portfolio of QIAstat-Dx syndromic testing systems and panels, including an expanded Meningitis/Encephalitis (ME) Panel for the ...
Screening cancer patients for microsatellite instability (MSI) can provide pathologists, oncologists, and patients with information that characterizes tumors to help guide care and make more informed ...
Qiagen receives US FDA clearance for gastrointestinal panels on fully automated QIAstat-Dx Rise Syndromic Testing System: Frankfurt Friday, March 13, 2026, 11:00 Hrs [IST] Qiagen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results